fullerene c60 has been researched along with Atheroma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bivol, VG; Dumitrescu, M; Fenyo, IM; Gafencu, AV; Simionescu, M; Tudorache, IF | 1 |
| Dellinger, AL; Elias, MG; Kepley, CL; Plotkin, JD | 1 |
| Dellinger, A; Kepley, CL; Link, K; Olson, J; Sandros, MG; Vance, S; Yang, J; Zhou, Z | 1 |
3 other study(ies) available for fullerene c60 and Atheroma
| Article | Year |
|---|---|
Synthetic lipoproteins based on apolipoprotein E coupled to fullerenol have anti-atherosclerotic properties.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cholesterol; Fullerenes; Mice; Mice, Knockout; Plaque, Atherosclerotic | 2022 |
NF-κB inhibitors that prevent foam cell formation and atherosclerotic plaque accumulation.
Topics: Animals; Cells, Cultured; Foam Cells; Fullerenes; Humans; Male; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; NF-kappa B; Plaque, Atherosclerotic; U937 Cells | 2017 |
Functionalization of gadolinium metallofullerenes for detecting atherosclerotic plaque lesions by cardiovascular magnetic resonance.
Topics: Animals; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Blotting, Western; CD36 Antigens; Contrast Media; Disease Models, Animal; Foam Cells; Fullerenes; Humans; Ligands; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Electron, Scanning; Organometallic Compounds; Plaque, Atherosclerotic; Predictive Value of Tests; Time Factors; U937 Cells | 2013 |